Ledger.Open graph →
SEC Form D · filed April 16, 2020

Zikani Therapeutics, Inc

Offering
$7.5M
Sold
$7.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Watertown, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Sumit Aggarwal · Watertown, MAExec · DirectorChristopher A. Viehbacher · Watertown, MADirectorRaj B. Parekh, Ph.D · Watertown, MADirectorSumit Aggarwal · Watertown, MAExec · DirectorChristopher A. Viehbacher · Watertown, MADirectorRaj B. Parekh, Ph.D · Watertown, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗